BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

15 articles for M Whittaker

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis.EBI
Oxagen
Structure--activity relationships of the peptide deformylase inhibitor BB-3497: modification of the P2' and P3' side chains.EBI
British Biotech Pharmaceuticals
 
Cyclic ether acetal platelet activating factor (PAF) receptor antagonists II: imidazo[4,5-c]pyridyl derivativesEBI
TBA
 
Cyclic ether acetal platelet activating factor (PAF) receptor antagonists I: 3-pyridyl derivativesEBI
TBA
 
A partial pharmacophore for the platelet activating factor (PAF) receptorEBI
TBA
Novel 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohepta[f]indene analogues as potent and selective 5-HT(2C) agonists for the treatment of metabolic disorders.EBI
Evotec
An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction.EBI
Evotec (Uk)
 
Inhibition of Matrix Metalloproteinases: An examination of the S1′ pocketEBI
TBA
Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.EBI
Oxagen
Peptide deformylase inhibitors with activity against respiratory tract pathogens.EBI
British Biotech Pharmaceuticals
Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the methylene spacer and the P1' side chain.EBI
British Biotech Pharmaceuticals
Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the metal binding group.EBI
British Biotech Pharmaceuticals
Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.EBI
British Biotech Pharmaceuticals
The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.EBI
British Biotech Pharmaceuticals